Aspen Aerogels (NYSE:ASPN – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports.
Other equities analysts also recently issued reports about the company. B. Riley Financial restated a “buy” rating on shares of Aspen Aerogels in a research note on Friday, August 7th. Weiss Ratings restated a “sell (d-)” rating on shares of Aspen Aerogels in a research report on Monday, September 21st. Roth Capital reissued a “buy” rating and set a $7.75 target price on shares of Aspen Aerogels in a research report on Friday, August 7th. Finally, Barclays boosted their target price on shares of Aspen Aerogels from $4.00 to $5.00 and gave the stock an “underweight” rating in a report on Tuesday, August 11th. Four equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, Aspen Aerogels currently has a consensus rating of “Hold” and an average price target of $5.94.
Check Out Our Latest Stock Report on Aspen Aerogels
Aspen Aerogels Stock Up 0.2%
Shares of NYSE ASPN opened at $5.06 on Friday. The firm has a market cap of $419.92 million, a PE ratio of -3.31 and a beta of 3.06. Aspen Aerogels has a 1 year low of $2.30 and a 1 year high of $8.56. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.52 and a quick ratio of 2.24. The company has a 50 day simple moving average of $5.25 and a 200 day simple moving average of $4.67.
Aspen Aerogels (NYSE:ASPN – Get Free Report) last issued its earnings results on Thursday, August 6th. The construction company reported ($0.22) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.01. Aspen Aerogels had a negative net margin of 62.45% and a negative return on equity of 31.12%. The firm had revenue of $49.85 million during the quarter, compared to analyst estimates of $42.42 million. Aspen Aerogels has set its Q3 2026 guidance at -0.110–0.070 EPS. On average, research analysts forecast that Aspen Aerogels will post -0.69 EPS for the current year.
Insider Transactions at Aspen Aerogels
In other news, major shareholder Wood River Capital, Llc sold 12,280,426 shares of Aspen Aerogels stock in a transaction that occurred on Wednesday, September 23rd. The shares were sold at an average price of $4.73, for a total value of $58,086,414.98. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 2.96% of the stock is owned by corporate insiders.
Institutional Trading of Aspen Aerogels
Several institutional investors and hedge funds have recently modified their holdings of ASPN. Legal & General Group Plc acquired a new position in Aspen Aerogels in the second quarter valued at $44,000. Royal Bank of Canada increased its stake in shares of Aspen Aerogels by 95.8% in the first quarter. Royal Bank of Canada now owns 8,523 shares of the construction company’s stock worth $29,000 after purchasing an additional 4,169 shares in the last quarter. Pallas Capital Advisors LLC acquired a new position in Aspen Aerogels during the second quarter valued at $69,000. Equitable Holdings Inc. acquired a new stake in shares of Aspen Aerogels during the second quarter worth about $88,000. Finally, Hsbc Holdings PLC acquired a new stake in shares of Aspen Aerogels during the second quarter valued at about $86,000. Institutional investors own 97.64% of the company’s stock.
About Aspen Aerogels
Aspen Aerogels, Inc is an advanced materials company that develops, manufactures and sells aerogel-based products. Aerogels are highly porous materials used for thermal management, insulation and protection. The company serves customers in the energy, industrial, transportation and building materials markets.
Its product portfolio includes thermal barriers designed to help protect electric vehicle batteries from thermal runaway, as well as insulation products for industrial, energy infrastructure and building applications.
Further Reading
- Five stocks we like better than Aspen Aerogels
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.
